Literature DB >> 18691507

The role of smooth muscle derived tissue factor in mediating thrombosis and arterial injury.

Mark B Taubman1, Li Wang, Christine Miller.   

Abstract

Tissue factor (TF) is a glycoprotein that initiates coagulation, regulates hemostasis and plays a critical role in arterial thrombosis. Vascular smooth muscle cells (SMC) are the major cellular component of the arterial wall. Under normal conditions, SMC express minimal levels of TF; however TF is rapidly induced in SMC by growth factors and cytokines and is expressed in abundance in arterial SMC in response to injury and during atherogenesis. Recent studies have suggested that SMC-derived TF plays an important role in promoting arterial thrombosis and in mediating intimal hyperplasia in response to arterial injury. This latter role may be related to non-procoagulant properties of TF.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18691507     DOI: 10.1016/S0049-3848(08)70025-2

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  6 in total

1.  Lysophosphatidic acid effects on atherosclerosis and thrombosis.

Authors:  Mei-Zhen Cui
Journal:  Clin Lipidol       Date:  2011-08

2.  Targeting STUB1-tissue factor axis normalizes hyperthrombotic uremic phenotype without increasing bleeding risk.

Authors:  Moshe Shashar; Mostafa E Belghasem; Shinobu Matsuura; Joshua Walker; Sean Richards; Faisal Alousi; Keshab Rijal; Vijaya B Kolachalama; Mercedes Balcells; Minami Odagi; Kazuo Nagasawa; Joel M Henderson; Amitabh Gautam; Richard Rushmore; Jean Francis; Daniel Kirchhofer; Kumaran Kolandaivelu; David H Sherr; Elazer R Edelman; Katya Ravid; Vipul C Chitalia
Journal:  Sci Transl Med       Date:  2017-11-22       Impact factor: 17.956

3.  Proteomic Profiling Exosomes from Vascular Smooth Muscle Cell.

Authors:  Hong Qiu; Songshan Shi; Shunchun Wang; Hong Peng; Shi-Jian Ding; Lianchun Wang
Journal:  Proteomics Clin Appl       Date:  2018-06-05       Impact factor: 3.494

4.  Indoleamine 2,3-dioxygenase-1, a Novel Therapeutic Target for Post-Vascular Injury Thrombosis in CKD.

Authors:  Joshua A Walker; Sean Richards; Stephen A Whelan; Sung Bok Yoo; Teresa L Russell; Nkiruka Arinze; Saran Lotfollahzadeh; Marc A Napoleon; Mostafa Belghasem; Norman Lee; Laura M Dember; Katya Ravid; Vipul C Chitalia
Journal:  J Am Soc Nephrol       Date:  2021-11       Impact factor: 10.121

5.  Vitamin K antagonist use induces calcification and atherosclerotic plaque progression resulting in increased hypercoagulability.

Authors:  Rick H van Gorp; Constance C F M J Baaten; Anxhela Habibi; Armand M G Jaminon; Frederique E C M Peeters; Peter Leenders; Harry J G M C Crijns; Johan W M Heemskerk; Chris P Reutelingsperger; Henri M Spronk; Leon J Schurgers
Journal:  Eur Heart J Open       Date:  2021-08-06

6.  Improved MSC Minimal Criteria to Maximize Patient Safety: A Call to Embrace Tissue Factor and Hemocompatibility Assessment of MSC Products.

Authors:  Guido Moll; James A Ankrum; Scott D Olson; Jan A Nolta
Journal:  Stem Cells Transl Med       Date:  2022-03-03       Impact factor: 7.655

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.